Unknown file type. Enclosure URL IS: - http://feedproxy.google.com/~r/BiotechNow/~5/tgmAPX9GPOw/FINAL%20BIO%20Comments%20on%20INPI%20Proposed%20Guidelines.pdf
Summary: The Government of Brazil approaches the patent policy crossroads with two ministries wanting to move in opposite directions. In the last few months, both the Brazilian Patent Office (INPI) and the Brazilian Regulatory Authority (ANVISA) issued proposed rules concerning patents and are sifting through public comments to determine how they will deal with biotech patents. A quirk in Brazilian law requires that the health regulatory authority (ANVISA) must provide “prior consent” on the grant of a pharmaceutical patent. Traditionally, Read More
